Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases

The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Soo-Kyung, Choi, Chang Hwan, Chun, Jaeyoung, Lee, Heeyoung, Kim, Eun Sun, Park, Jae Jun, Park, Chan Hyuk, Lee, Bo-In, Jung, Yunho, Park, Dong-Il, Kim, Do Young, Park, Hana, Jeen, Yoon Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000641/
https://www.ncbi.nlm.nih.gov/pubmed/32013312
http://dx.doi.org/10.5217/ir.2019.09155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000641/
https://www.ncbi.nlm.nih.gov/pubmed/32013312
http://dx.doi.org/10.5217/ir.2019.09155

Ejemplares similares